drugset / Trial / NCT02575703

A Study of [¹⁴C]-LY3023414 in Healthy Participants

NCT02575703

Phase 1 Completed 8 enrolled Eli Lilly and Company
NaSingle-groupOpen-labelBasic science

Summary

This type of study is called a radiolabeled study. For this study, LY3023414 has been specially prepared to contain the radioactive carbon atom \[¹⁴C\]. \[¹⁴C\] is a naturally occurring radioactive form of the element carbon. Adding a low dose of radiation to the study drug does not change how the drug works but helps to identify when the drug appears in the blood, urine, breath, and stool after it is given. The study will last about 15 days for each participant, not including screening. Screening is required within 28 days prior to enrollment. This study is for research purposes only and is not intended to treat any medical condition.

Timeline

Start
2015-10
Primary completion
2015-11
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Samotolisib Small molecule Oral

Indications

No indication recorded.